Clinical Trial Update: Latanoprost Preserved Versus Unpreserved: Effect on Tear Film Thickness as Measured With OCT [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update comparing latanoprost preserved vs unpreserved on tear film thickness measured by OCT in glaucoma and ocular hypertension patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Latanoprost (Latanoprost)

Snippet

Sponsor: Medical University of Vienna | Conditions: Glaucoma, Ocular Hypertension | Phase 4 | Status: UNKNOWN